In situ proximity ligation detection of c-Jun/AP-1 dimers reveals increased levels of c-Jun/Fra1 complexes in aggressive breast cancer cell lines in vitro and in vivo

Molecular and Cellular Proteomics

Volumn 9, Issue 9, 2010, Pages 1982-1990

  Baan, Bart ^a   Pardali, Evangelia ^a   Ten Dijke, Peter ^a,b   Van Dam, Hans ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DIMER; MUTANT PROTEIN; PROTEIN C FOS; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER TISSUE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COMPLEX FORMATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; ONCOGENE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROXIMITY LIGATION ASSAY; QUANTITATIVE ANALYSIS; REGULATORY MECHANISM; VALIDATION PROCESS;

BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; DIMERIZATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; MUTATION; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; TRANSCRIPTION FACTOR AP-1;

EID: 77956550866     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.000943     Document Type: Article

References (52)

1. Shaulian, E., and Karin, M. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4, E131-E136
2. Shaulian, E., and Karin, M. (2001) AP-1 in cell proliferation and survival. Oncogene 20, 2390-2400
3. Karin, M., Liu, Z., and Zandi, E. (1997) AP-1 function and regulation. Curr. Opin. Cell Biol. 9, 240-246
4. van Dam, H., and Castellazzi, M. (2001) Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene 20, 2453-2464
5. Diefenbacher, M., Sekula, S., Heilbock, C., Maier, J. V., Litfin, M., van Dam, H., Castellazzi, M., Herrlich, P., and Kassel, O. (2008) Restriction to Fos family members of Trip6-dependent coactivation and glucocorticoid receptor-dependent trans-repression of activator protein-1. Mol. Endocrinol. 22, 1767-1780
6. Ciapponi, L., and Bohmann, D. (2002) An essential function of AP-1 heterodimers in Drosophila development. Mech. Dev. 115, 35-40 (Pubitemid 34615665)
7. Hess, J., Angel, P., and Schorpp-Kistner, M. (2004) AP-1 subunits: quarrel and harmony among siblings. J. Cell Sci. 117, 5965-5973 (Pubitemid 40123963)
8. Lopez-Bergami, P., Lau, E., and Ronai, Z. (2010) Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat. Rev. Cancer. 10, 65-76
9. Mechta-Grigoriou, F., Gerald, D., and Yaniv, M. (2001) The mammalian Jun proteins: redundancy and specificity. Oncogene 20, 2378-2389 (Pubitemid 32531296)
10. Suzukawa, K., and Colburn, N. H. (2002) AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Oncogene 21, 2181-2190
11. Verde, P., Casalino, L., Talotta, F., Yaniv, M., and Weitzman, J. B. (2007) Deciphering AP-1 function in tumorigenesis: fra-ternizing on target promoters. Cell Cycle 6, 2633-2639
12. Vinson, C., Myakishev, M., Acharya, A., Mir, A. A., Moll, J. R., and Bonovich, M. (2002) Classification of human B-ZIP proteins based on dimerization properties. Mol. Cell. Biol. 22, 6321-6335
13. Bakiri, L., Matsuo, K., Wisniewska, M., Wagner, E. F., and Yaniv, M. (2002) Promoter specificity and biological activity of tethered AP-1 dimers. Mol. Cell. Biol. 22, 4952-4964 (Pubitemid 34620427)
14. Bakiri, L., Takada, Y., Radolf, M., Eferl, R., Yaniv, M., Wagner, E. F., and Matsuo, K. (2007) Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation. Bone 40, 867-875 (Pubitemid 46386538)
15. Yuan, Z., Gong, S., Luo, J., Zheng, Z., Song, B., Ma, S., Guo, J., Hu, C., Thiel, G., Vinson, C., Hu, C. D., Wang, Y., and Li, M. (2009) Opposing roles for ATF2 and c-Fos in c-Jun-mediated neuronal apoptosis. Mol. Cell. Biol. 29, 2431-2442
16. Eferl, R., and Wagner, E. F. (2003) AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868
17. Zenz, R., and Wagner, E. F. (2006) Jun signalling in the epidermis: from developmental defects to psoriasis and skin tumors. Int. J. Biochem. Cell Biol. 38, 1043-1049
18. Durchdewald, M., Angel, P., and Hess, J. (2009) The transcription factor Fos: a Janus-type regulator in health and disease. Histol. Histopathol. 24, 1451-1461
19. Young, M. R., and Colburn, N. H. (2006) Fra-1 a target for cancer prevention or intervention. Gene 379, 1-11
20. Bamberger, A. M., Methner, C., Lisboa, B. W., Städtler, C., Schulte, H. M., Löning, T., and Milde-Langosch, K. (1999) Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype. Int. J. Cancer 84, 533-538
21. Chiappetta, G., Ferraro, A., Botti, G., Monaco, M., Pasquinelli, R., Vuttariello, E., Arnaldi, L., Di Bonito, M., D'Aiuto, G., Pierantoni, G. M., and Fusco, A. (2007) FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. BMC Cancer 7, 17
22. Luo, Y. P., Zhou, H., Krueger, J., Kaplan, C., Liao, D., Markowitz, D., Liu, C., Chen, T., Chuang, T. H., Xiang, R., and Reisfeld, R. A. (2010) The role of proto-oncogene Fra-1 in remodeling the tumor microenvironment in support of breast tumor cell invasion and progression. Oncogene 29, 662-673
23. Maekawa, T., Shinagawa, T., Sano, Y., Sakuma, T., Nomura, S., Nagasaki, K., Miki, Y., Saito-Ohara, F., Inazawa, J., Kohno, T., Yokota, J., and Ishii, S. (2007) Reduced levels of ATF-2 predispose mice to mammary tumors. Mol. Cell. Biol. 27, 1730-1744 (Pubitemid 46310039)
24. Ozanne, B. W., Spence, H. J., McGarry, L. C., and Hennigan, R. F. (2007) Transcription factors control invasion: AP-1 the first among equals. Oncogene 26, 1-10
25. Yin, X., Dewille, J. W., and Hai, T. (2008) A potential dichotomous role of ATF3, an adaptive-response gene, in cancer development. Oncogene 27, 2118-2127
26. Belguise, K., Kersual, N., Galtier, F., and Chalbos, D. (2005) FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 24, 1434-1444
27. Milde-Langosch, K., Röder, H., Andritzky, B., Aslan, B., Hemminger, G., Brinkmann, A., Bamberger, C. M., Löning, T., and Bamberger, A. M. (2004) The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas. Breast Cancer Res. Treat. 86, 139-152
28. Söderberg, O., Gullberg, M., Jarvius, M., Ridderstråle, K., Leuchowius, K. J., Jarvius, J., Wester, K., Hydbring, P., Bahram, F., Larsson, L. G., and Landegren, U. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat. Methods 3, 995-1000 (Pubitemid 44782698)
29. Jarvius, M., Paulsson, J., Weibrecht, I., Leuchowius, K. J., Andersson, A. C., Wählby, C., Gullberg, M., Botling, J., Sjöblom, T., Markova, B., Ostman, A., Landegren, U., and Söderberg, O. (2007) In situ detection of phosphorylated platelet-derived growth factor receptor beta using a generalized proximity ligation method. Mol. Cell. Proteomics 6, 1500-1509 (Pubitemid 47506163)
30. Banér, J., Nilsson, M., Mendel-Hartvig, M., and Landegren, U. (1998) Signal amplification of padlock probes by rolling circle replication. Nucleic Acids Res. 26, 5073-5078 (Pubitemid 28517561)
31. van Dam, H., Offringa, R., Meijer, I., Stein, B., Smits, A. M., Herrlich, P., Bos, J. L., and van der Eb, A. J. (1990) Differential effects of the adenovirus E1A oncogene on members of the AP-1 transcription factor family. Mol. Cell. Biol. 10, 5857-5864 (Pubitemid 20341456)
32. Angel, P., Smeal, T., Meek, J., and Karin, M. (1989) Jun and v-jun contain multiple regions that participate in transcriptional activation in an interdependent manner. New Biol. 1, 35-43
33. van Dam, H., Huguier, S., Kooistra, K., Baguet, J., Vial, E., van der Eb, A. J., Herrlich, P., Angel, P., and Castellazzi, M. (1998) Autocrine growth and anchorage independence: two complementing Jun-controlled genetic programs of cellular transformation. Genes Dev. 12, 1227-1239
34. Treier, M., Staszewski, L. M., and Bohmann, D. (1994) Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain. Cell 78, 787-798
35. Deckers, M., van Dinther, M., Buijs, J., Que, I., Löwik, C., van derPluijm, G., and ten Dijke, P. (2006) The tumor suppressor Smad4 is required for transforming growth factor beta-induced epithelial to mesenchymal transition and bone metastasis of breast cancer cells. Cancer Res. 66, 2202-2209
36. van Dam, H., Duyndam, M., Rottier, R., Bosch, A., de Vries-Smits, L., Herrlich, P., Zantema, A., Angel, P., and van der Eb, A. J. (1993) Heterodimer formation of cJun and ATF-2 is responsible for induction of c-jun by the 243 amino acid adenovirus E1A protein. EMBO J. 12, 479-487
37. Ouwens, D. M., de Ruiter, N. D., van der Zon, G. C., Carter, A. P., Schouten, J., van der Burgt, C., Kooistra, K., Bos, J. L., Maassen, J. A., and van Dam, H. (2002) Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38. EMBO J. 21, 3782-3793 (Pubitemid 34787051)
38. Allalou, A., and Wählby, C. (2009) BlobFinder, a tool for fluorescence microscopy image cytometry. Comput. Methods Programs Biomed. 94, 58-65
39. Milde-Langosch, K. (2005) The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer 41, 2449-2461 (Pubitemid 41540622)
40. Jochum, W., Passegué, E., and Wagner, E. F. (2001) AP-1 in mouse development and tumorigenesis. Oncogene 20, 2401-2412
41. Hamdi, M., Popeijus, H. E., Carlotti, F., Janssen, J. M., van der Burgt, C., Cornelissen-Steijger, P., van de Water, B., Hoeben, R. C., Matsuo, K., and van Dam, H. (2008) ATF3 and Fra1 have opposite functions in JNK- and ERK-dependent DNA damage responses. DNA Repair 7, 487-496
42. Bhoumik, A., Lopez-Bergami, P., and Ronai, Z. (2007) ATF2 on the double-activating transcription factor and DNA damage response protein. Pigment Cell Res. 20, 498-506 (Pubitemid 47568834)
43. Herrlich, P., Karin, M., and Weiss, C. (2008) Supreme EnLIGHTenment: damage recognition and signaling in the mammalian UV response. Mol. Cell 29, 279-290
44. Potapova, O., Basu, S., Mercola, D., and Holbrook, N. J. (2001) Protective role for c-Jun in the cellular response to DNA damage. J. Biol. Chem. 276, 28546-28553
45. MacLaren, A., Black, E. J., Clark, W., and Gillespie, D. A. (2004) c-Jun-deficient cells undergo premature senescence as a result of spontaneous DNA damage accumulation. Mol. Cell. Biol. 24, 9006-9018
46. Blick, T., Widodo, E., Hugo, H., Waltham, M., Lenburg, M. E., Neve, R. M., and Thompson, E. W. (2008) Epithelial mesenchymal transition traits in human breast cancer cell lines. Clin. Exp. Metastasis 25, 629-642
47. Rae, J. M., Creighton, C. J., Meck, J. M., Haddad, B. R., and Johnson, M. D. (2007) MDA-MB-435 cells are derived from M14 melanoma cells - a loss for breast cancer, but a boon for melanoma research. Breast Cancer Res. Treat. 104, 13-19
48. Zajchowski, D. A., Bartholdi, M. F., Gong, Y., Webster, L., Liu, H. L., Munishkin, A., Beauheim, C., Harvey, S., Ethier, S. P., and Johnson, P. H. (2001) Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 61, 5168-5178
49. Liu, H., Deng, X., Shyu, Y. J., Li, J. J., Taparowsky, E. J., and Hu, C. D. (2006) Mutual regulation of c-Jun and ATF2 by transcriptional activation and subcellular localization. EMBO J. 25, 1058-1069
50. Hu, C. D., Chinenov, Y., and Kerppola, T. K. (2002) Visualization of interactions among bZIP and Rel family proteins in living cells using bimolecular fluorescence complementation. Mol. Cell 9, 789-798
51. Maekawa, T., Sano, Y., Shinagawa, T., Rahman, Z., Sakuma, T., Nomura, S., Licht, J. D., and Ishii, S. (2008) ATF-2 controls transcription of Maspin and GADD45 alpha genes independently from p53 to suppress mammary tumors. Oncogene 27, 1045-1054
52. Vleugel, M. M., Greijer, A. E., Bos, R., van der Wall, E., and van Diest, P. J. (2006) c-Jun activation is associated with proliferation and angiogenesis in invasive breast cancer. Hum. Pathol. 37, 668-674 (Pubitemid 43956532)